Contact this trialFirst, we need to learn more about you.
Checkpoint Inhibitor
Nivolumab for Skin Cancer
Recruiting2 awardsPhase 2
New Brunswick, New Jersey
This trial is testing nivolumab to treat patients with stage IIB-IIC melanoma. Monoclonal antibodies, like nivolumab, may stop tumor cells from growing and spreading.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.